Published in Am J Psychiatry on September 01, 1995
Predictive value of family history on severity of illness: the case for depression, anxiety, alcohol dependence, and drug dependence. Arch Gen Psychiatry (2009) 1.41
A comparison between screened NIMH and clinically interviewed control samples on neuroticism and extraversion. Mol Psychiatry (2007) 1.31
Panic, suffocation false alarms, separation anxiety and endogenous opioids. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.08
SEPARATION ANXIETY DISORDER IN YOUTH: PHENOMENOLOGY, ASSESSMENT, AND TREATMENT. Psicol Conductual (2008) 0.99
Unstable maternal environment, separation anxiety, and heightened CO2 sensitivity induced by gene-by-environment interplay. PLoS One (2011) 0.97
Panic disorder is associated with the serotonin transporter gene (SLC6A4) but not the promoter region (5-HTTLPR). Mol Psychiatry (2008) 0.95
The prevalence and correlates of adult separation anxiety disorder in an anxiety clinic. BMC Psychiatry (2010) 0.93
Anxiety in middle adulthood: effects of age and time on the 14-year course of panic disorder, social phobia and generalized anxiety disorder. Psychol Med (2008) 0.89
Sex differences in anxiety and emotional behavior. Pflugers Arch (2013) 0.87
Separation anxiety: at the neurobiological crossroads of adaptation and illness. Dialogues Clin Neurosci (2015) 0.80
Panic disorder in clinically referred children and adolescents. Child Psychiatry Hum Dev (2000) 0.80
Physiological, biochemical and subjective parameters in anxiety patients with panic disorder during stress exposure as compared with healthy controls. Eur Arch Psychiatry Clin Neurosci (1997) 0.80
Development × environment interactions control tph2 mRNA expression. Neuroscience (2013) 0.79
Anxiety, mood, and substance use disorders in parents of children with anxiety disorders. Child Psychiatry Hum Dev (2009) 0.78
The Deakin/Graeff hypothesis: focus on serotonergic inhibition of panic. Neurosci Biobehav Rev (2014) 0.78
Evidence that the periaqueductal gray matter mediates the facilitation of panic-like reactions in neonatally-isolated adult rats. PLoS One (2014) 0.76
Lifelong opioidergic vulnerability through early life separation: a recent extension of the false suffocation alarm theory of panic disorder. Neurosci Biobehav Rev (2014) 0.76
Neonatal Maternal Separation Augments Carotid Body Response to Hypoxia in Adult Males but Not Female Rats. Front Physiol (2016) 0.75
Panic disorder in children and adolescents with noncardiac chest pain. Child Psychiatry Hum Dev (2013) 0.75
Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet (1999) 1.98
Clostridium perfringens Type A Food Poisoning II. Response of the Rabbit Ileum as an Indication of Enteropathogenicity of Strains of Clostridium perfringens in Human Beings. Infect Immun (1971) 1.73
Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry (2012) 1.57
Modulation by muscarinic antagonists of the response to carbon dioxide challenge in panic disorder. Arch Gen Psychiatry (2001) 1.56
Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study. Gynecol Oncol (2001) 1.51
Antibodies against rifampin in patients with tuberculosis after discontinuation of daily treatment. Am Rev Respir Dis (1976) 1.43
[18F]FDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment. Br J Psychiatry (1995) 1.23
The Iowa Personality Disorder Screen: development and preliminary validation of a brief screening interview. J Pers Disord (1999) 1.17
Decision-making heterogeneity in obsessive-compulsive disorder: ventromedial prefrontal cortex function predicts different treatment outcomes. Neuropsychologia (2002) 1.15
Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes (2000) 1.13
Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients. Br J Cancer (2004) 1.10
Clinical predictors of drug response in obsessive-compulsive disorder. J Clin Psychopharmacol (2001) 1.09
Frequency of left atrial thrombi by transesophageal echocardiography in idiopathic and in ischemic dilated cardiomyopathy. Am J Cardiol (1992) 1.05
Disorganization of anatomical connectivity in obsessive compulsive disorder: a multi-parameter diffusion tensor imaging study in a subpopulation of patients. Neurobiol Dis (2009) 1.05
Sensitivity to 35% CO2 in healthy first-degree relatives of patients with panic disorder. Am J Psychiatry (1995) 1.02
The cooccurrence of DSM-III-R personality disorders. J Pers Disord (1998) 1.01
Comparative bioavailability of isoniazid, rifampin, and pyrazinamide administered in free combination and in a fixed triple formulation designed for daily use in antituberculosis chemotherapy. II. Two-month, daily administration study. Am Rev Respir Dis (1988) 0.98
Complex segregation analysis for obsessive compulsive disorder and related disorders. Am J Med Genet (1999) 0.98
Phase II study of paclitaxel as salvage treatment in advanced endometrial cancer. Ann Oncol (1996) 0.96
CO2-induced panic attacks: a twin study. Am J Psychiatry (1998) 0.96
Phase II study of capecitabine and oxaliplatin as first-line treatment in advanced colorectal cancer. Ann Oncol (2003) 0.95
Temperament dimensions explain the comorbidity of psychiatric disorders. Compr Psychiatry (1996) 0.94
VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2. Br J Cancer (2012) 0.93
Serotonin transporter linked polymorphic region in anorexia nervosa and bulimia nervosa. Mol Psychiatry (2000) 0.93
First-cycle REM density in never-depressed subjects with borderline personality disorder. Biol Psychiatry (1999) 0.93
The unipolar-bipolar dichotomy and the response to sleep deprivation. Psychiatry Res (1998) 0.93
Plasma interleukin-1 beta and tumor necrosis factor concentrations in obsessive-compulsive disorders. Biol Psychiatry (1997) 0.92
Thyroid hormone receptor alpha 1: a switch to cardiac cell "metamorphosis"? J Physiol Pharmacol (2008) 0.91
Hypersensitivity to inhalation of carbon dioxide and panic attacks. Psychiatry Res (1995) 0.90
Cisplatin-, epirubicin- and paclitaxel-containing chemotherapy in uterine adenocarcinoma. Ann Oncol (1997) 0.89
Effect of hyaluronic acid on human chondrocyte cell lines from articular cartilage. Tissue Cell (2001) 0.88
Predictive value of obsessive-compulsive personality disorder in antiobsessional pharmacological treatment. Eur Neuropsychopharmacol (1997) 0.88
Ambulatory polysomnography of never-depressed borderline subjects: a high-risk approach to rapid eye movement latency. Biol Psychiatry (1993) 0.87
Family history of panic disorder and hypersensitivity to CO2 in patients with panic disorder. Am J Psychiatry (1996) 0.87
A family study of schizotypal disorder. Schizophr Bull (1995) 0.86
Functional promoter polymorphism of the human serotonin transporter: lack of association with panic disorder. Psychiatr Genet (1997) 0.86
Effect of adjuvant pindolol on the antiobsessional response to fluvoxamine: a double-blind, placebo-controlled study. Int Clin Psychopharmacol (1998) 0.86
Asthma and panic attacks. Biol Psychiatry (1997) 0.86
Insomnia as a predictor of high-lethality suicide attempts. Int J Clin Pract (2013) 0.86
Ophthalmological manifestations in segmental neurofibromatosis type 1. Br J Ophthalmol (2004) 0.85
An association study between 5-HTTLPR polymorphism, COMT polymorphism, and Tourette's syndrome. Psychiatry Res (2000) 0.85
The 5-HT(2A) -1438G/A polymorphism in anorexia nervosa: a combined analysis of 316 trios from six European centres. Mol Psychiatry (2002) 0.85
Paclitaxel, ifosfamide and cisplatin (TIP) chemotherapy for recurrent or persistent squamous-cell cervical cancer. Ann Oncol (1999) 0.85
Prognostic impact of HER2/neu protein in urothelial bladder cancer. Survival analysis of 80 cases and an overview of almost 20 years' research. J BUON (2009) 0.85
Central dopaminergic function in anorexia and bulimia nervosa: a psychoneuroendocrine approach. Psychoneuroendocrinology (2001) 0.85
Obsessive-Compulsive Disorder, 5-HTTLPR polymorphism and treatment response. Pharmacogenomics J (2002) 0.85
Plasma interleukin-1 beta concentrations in panic disorder. Psychiatry Res (1994) 0.85
[Recurrent brown tumors as initial manifestation of primary hyperparathyroidism. An unusual presentation]. Minerva Med (2000) 0.84
Alpha 2-adrenergic receptor sensitivity in panic disorder: I. GH response to GHRH and clonidine stimulation in panic disorder. Psychoneuroendocrinology (1995) 0.84
Panic disorder: the role of the balance system. J Psychiatr Res (2001) 0.84
Comparison of the treatment with paroxetine and reboxetine in panic disorder: a randomized, single-blind study. Pharmacopsychiatry (2004) 0.84
Vestibular testing in patients with panic disorder and chronic dizziness. Acta Otorhinolaryngol Ital (2007) 0.84
Obsessive compulsive disorder and mood disorders: a family study. Am J Med Genet (1995) 0.84
Laboratory response of patients with panic and obsessive-compulsive disorders to 35% CO2 challenges. Am J Psychiatry (1995) 0.84
Physiological and behavioral responses to minor stressors in offspring of patients with panic disorder. J Psychiatr Res (1997) 0.83
Tryptophan depletion in obsessive-compulsive patients. Biol Psychiatry (1996) 0.83
Frontal lobe dysfunction in schizophrenia and obsessive-compulsive disorder: a neuropsychological study. Brain Cogn (1995) 0.83
Molecular diagnosis of p53 mutations in gastric carcinoma by touch preparation. Am J Pathol (1996) 0.83
Complex segregation analysis of obsessive-compulsive disorder in 141 families of eating disorder probands, with and without obsessive-compulsive disorder. Am J Med Genet (2000) 0.83
Peripheral anxiogenic drug injections differentially affect cognitive and habit memory: role of basolateral amygdala. Neuroscience (2009) 0.83
EEG power modifications in panic disorder during a temporolimbic activation task: relationships with temporal lobe clinical symptomatology. J Neuropsychiatry Clin Neurosci (1993) 0.83
A comparison of citalopram and paroxetine in the treatment of panic disorder: a randomized, single-blind study. Pharmacopsychiatry (2001) 0.82
Carbon dioxide/oxygen challenge test in panic disorder. Psychiatry Res (1994) 0.82
Polycyclic aromatic hydrocarbons (PaHs) in subcutaneous biopsies of Mediterranean cetaceans. Chemosphere (2001) 0.81
Combined family trio and case-control analysis of the COMT Val158Met polymorphism in European patients with anorexia nervosa. Am J Med Genet B Neuropsychiatr Genet (2004) 0.81
The 35% CO2 challenge test in patients with social phobia. Psychiatry Res (1997) 0.81
Pharmacokinetic study on intravenous rifampicin in man. Pharmacol Res Commun (1984) 0.81
Menstrual cycle-related sensitivity to 35% CO2 in panic patients. Biol Psychiatry (1995) 0.81
5HT2C CYS23/SER23 polymorphism is not associated with obsessive-compulsive disorder. Psychiatry Res (1998) 0.81
Pharmacologic effect of imipramine, paroxetine, and sertraline on 35% carbon dioxide hypersensitivity in panic patients: a double-blind, random, placebo-controlled study. J Clin Psychopharmacol (1997) 0.81
Frontal lobe dysfunction in obsessive-compulsive disorder and major depression: a clinical-neuropsychological study. Psychiatry Res (1998) 0.81
Fertility-sparing surgery in uterine leiomyosarcoma. Gynecol Oncol (1998) 0.81
Plasma levels of tumor necrosis factor-alpha in patients with panic disorder: effect of alprazolam therapy. Psychiatry Res (1999) 0.81
Unusual recurrence of cervical adenosquamous carcinoma after conservative surgery. Gynecol Oncol (2000) 0.80
Human chondrocyte cell lines from articular cartilage of metatarsal phalangeal joints. Tissue Cell (1999) 0.80
Panic attacks: a twin study. Psychiatry Res (1997) 0.80
Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: a single-blind study. J Clin Psychopharmacol (1997) 0.80
Personality features related to generalized anxiety disorder. Compr Psychiatry (1990) 0.80
Efficacy and safety of azithromycin 1 g once daily for 3 days in the treatment of community-acquired pneumonia: an open-label randomised comparison with amoxicillin-clavulanate 875/125 mg twice daily for 7 days. J Chemother (2008) 0.80
MHPG, amitriptyline and affective disorders. A longitudinal study. Int Pharmacopsychiatry (1976) 0.80
Neurocognitive functioning in bulimia nervosa: the role of neuroendocrine, personality and clinical aspects. Psychol Med (2010) 0.80
Effect of acute intravenous clomipramine and antiobsessional response to proserotonergic drugs: is gender a predictive variable? Biol Psychiatry (1999) 0.80
Simultaneous determination of clomipramine and its desmethyl and hydroxy metabolites in plasma of patients by high-performance liquid chromatography after solid-phase extraction. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 0.80
Dizziness, migrainous vertigo and psychiatric disorders. J Laryngol Otol (2009) 0.79